# ITCH Trial: Protocol for a Randomized, Double Blind Placebo-controlled Trial

Study · id `cardio:ct-nct04742205` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04742205](<https://clinicaltrials.gov/study/NCT04742205>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT04742205

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 154 participants.

## Technical summary

Registry record NCT04742205. Randomized; triple masking; primary purpose treatment. Start 2021-02-08 (actual); primary completion 2023-12-05 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 2/3
- Enrolled: 154 participants (enrolled count; ClinicalTrials.gov record NCT04742205, source copy `cardio:ctgov-nct04742205-2025-03-19`, retrieved 2026-10-31)
- Started: 2021-02-08 (actual) (ClinicalTrials.gov record NCT04742205, source copy `cardio:ctgov-nct04742205-2025-03-19`, retrieved 2026-10-31)
- Primary completion: 2023-12-05 (actual) (ClinicalTrials.gov record NCT04742205, source copy `cardio:ctgov-nct04742205-2025-03-19`, retrieved 2026-10-31)
- Completion: 2024-06-04 (actual) (ClinicalTrials.gov record NCT04742205, source copy `cardio:ctgov-nct04742205-2025-03-19`, retrieved 2026-10-31)
- Countries: Nepal (ClinicalTrials.gov record NCT04742205, source copy `cardio:ctgov-nct04742205-2025-03-19`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04742205-2025-03-19`, retrieved 2026-10-31)

## The registry's words

- Brief title: ITCH Trial: Protocol for a Randomized, Double Blind Placebo-controlled Trial
- Condition: Cerebral Hemorrhage
- Intervention (Drug): Tranexamic Acid 500 MG
- Lead sponsor: Kathmandu Medical College and Teaching Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Bleeding in the brain (intracerebral hemorrhage) (`cardio:intracerebral-hemorrhage`)

## Provenance

Content hash: 0e450f037f60288aa8fa62e3e7fc8057659242b52511ceab60448b1467e060a4
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
